Retinitis Pigmentosa

Oct 11, 2022

Merck’s Sotatercept Trial Result; PARP Rivals Closing in on AstraZeneca and Merck’s Lynparza; FDA Clears GSK’s Boostrix for Pertussis; Fast Track Designation to Nanoscope Therapeutics’s MCO-010; FDA Awards Fast Track Designation to Eftilagimod Alpha Plus Pembrolizumab; Solid Biosciences to Acquire AavantiBio

Mar 27, 2020

What is driving Retinitis pigmentosa market forward?

Mar 23, 2020

Retinitis Pigmentosa: A complex disease, and the increasing gap between prevalence and diagnosed prevalence

Jan 16, 2018

Notizia

Jan 15, 2018

Retinal Degeneration : The Current Pipeline Scenario

Newsletter/Whitepaper